Pathology of transitional cell carcinoma of the bladder and its clinical implications

Seminars in Surgical Oncology

Volumn 13, Issue 5, 1997, Pages 307-318

  Lapham, Rosanna L ^a   Ro, Jae Y ^a,b   Staerkel, Gregg A ^a   Ayala, Alberto G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antigens; Biological tumor markers; Biopsy; Bladder neoplasms; Blood groups; Cystectomy; Differential diagnosis; Neoplasm invasiveness; Neoplasm staging; Prognosis; Survival rate; Transitional cell carcinoma

Indexed keywords

BLOOD GROUP ANTIGEN; DNA; PROTEIN P53;

ANTIGEN EXPRESSION; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CHROMOSOME ANALYSIS; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ABO BLOOD-GROUP SYSTEM; BLOOD VESSELS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERPROFESSIONAL RELATIONS; LYMPH NODES; MEDICAL RECORDS; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; PATHOLOGY; PROGNOSIS; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0030841339     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199709/10)13:5<307::AID-SSU4>3.0.CO;2-H     Document Type: Review

References (97)

1. Abel PD. Prognostic indices in transitional cell carcinoma of the bladder. [Review] Br J Urol 1988;62:103-109.
2. Harland SJ: Aggressive superficial bladder cancer. [editorial] [comment in Eur J Cancer 1994; 30A: 914-917] Eur J Cancer 1994;30A:899-900.
3. Whitmore WF Jr: Bladder cancer: An overview. [Review] CA Cancer J Clin 1988;38:213-223.
4. Betz SA, See WA, Cohen MB: Granulomatous inflammation in bladder wash specimens after intravesical bacillus Calmette-Guerin therapy for transitional cell carcinoma of the bladder. Am J Clin Pathol 1993;99:244-248.
5. Soloway MS: Overview of treatment of superficial bladder cancer. Urology 1985;26(4 Suppl):18-26.
6. Melamed MR: Introduction to cytology of the urinary tract. In Weid GL, Keebler CM, Koss LG, et al. (eds): "Compendium of Diagnostic Cytology." 6th ed. Chicago: International Academy of Cytology, 1988, 401-404.
7. Murphy WM: Current status of urinary cytology in the evaluation of bladder neoplasms. [Review] Hum Pathol 1990;21:886-896.
8. Forni AM, Koss LG, Geller W: Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man. Cancer 1964;17:1348-1355.
9. Loveless KJ: The effects of radiation upon the cytology of benign and malignant bladder epithelia. Acta Cytol 1973;17:355-360.
10. Stella F, Battistelli S, Marcheggiani F, et al: Urothelial toxicity following conditioning therapy in bone marrow transplantation and bladder cancer: morphologic and morphometric comparison by exfoliative urinary cytology. Diagn Cytopathol 1992;8:216-221.
11. Boon ME, Blomjous CE, Zwartendijk J, et al: Carcinoma in situ of the urinary bladder. Clinical presentation, cytologic pattern and stromal changes. Acta Cytol 1986;30:360-366.
12. Farrow GM: Urine cytology of transitional cell carcinoma. In Weid GL, Keebler JC, Koss LG, et al. (eds): "Compendium of Diagnostic Cytology." 6th ed. Chicago: International Academy of Cytology, 1988, 410-416.
13. Raab SS, Lenel JC, Cohen MB: Low grade transitional cell carcinoma of the bladder: Cytological diagnosis by key features as identified by logistic regression analysis. Cancer 1994;74:1621-1626.
14. Murphy WM, Soloway MS, Jukkola AF, et al: Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-1565.
15. Schwinn CP, Harris MJ: Exfoliative cytology of the urinary bladder. In Weid GL, Keebler CM, Koss LG, et al. (eds): "Compendium of Diagnostic Cytology." 6th ed. Chicago: International Academy of Cytology, 1988: 421-436.
16. Gonzalez-Zulueta M, Jones PA: Molecular biology of bladder cancer. In Vogelzang NJ, Scardino PS, Shipley WU, et al. (eds): "Comprehensive Textbook of Genitourinary Oncology." Baltimore: Williams and Wilkens, 1996, 314-325
17. Jewet HJ. Strong GH: Infiltrating carcinoma of the bladder: Relation of depth of penetration of bladder wall to incidence of local extension and metastases. J Urol 1946;55:366-372.
18. Beahrs OH, Hutler RV, Kennedy BJ, et al: "Manual for Staging of Cancer. American Joint Committee on Cancer." 4th ed. Philadelphia: JB Lippincott, 1992, 195-200.
19. Gospodarowicz MK: Staging of bladder cancer. [Review] Semin Surg Oncol 1994;10:51-59.
20. Soloway MS: Invasive bladder cancer selection of primary treatment. [Review] Semin Oncol 1990;17:551-554.
21. Association of Directors of Anatomic and Surgical Pathology: Recommendations for reporting of urinary bladder specimens containing bladder neoplasms. Hum Pathol 1996;27:751-752.
22. Ro JY, Ayala AG, el-Naggar A: Musculans mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 1987;11:668-673.
23. Mostofi FK, Sobin LH, Torloni H, et al: "Histological Typing of Urinary Bladder Tumors" International Classification of Tumours, no. 10. Geneva: World Health Organization, 1973, 15-36.
24. Dinney CP, Ramirez EI, Swanson DA, et al: Management of transitional cell carcinoma involving von Brunn's nests. J Urol 1995;153(3 Pt 2):944-949.
25. Kiemeney LA, Witjes JA, Heijbroek RP: Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. Eur J Cancer 1994;30A:1621-1625.
26. Vincente J, Laguna MP, Duarte D, et al: Carcinoma in situ as a prognostic factor for G3pT1 bladder tumors. Br J Urol 1991;68: 380-382.
27. Friedell GH, Parija GC, Kasy GK, Soto EA: The pathology of human bladder cancer. Cancer 1980;45(7 Suppl):1823-1831.
28. Amin MB, Murphy WM, Reuter VE, et al: A symposium on controversies in the pathology of transitional cell carcinoma of the urinary bladder, part 1. ASCP Rev Pathol 1996;1:1-39.
29. Weinstein RS, Coon JS, Schwanz D, et al: Pathology of superficial bladder cancer with emphasis on carcinoma in situ. [Review] Urology 1985;26(4 Suppl):2-10.
30. Kakizoe T, Matumoto K, Nishio Y, et al: Significance of carcinoma in situ and dysplasia in association with bladder cancer. J Urol 1985;133:395-398.
31. Seemayer TA, Knaack J, Thelmo WL, et al: Further observations on carcinoma in situ of the urinary bladder: Silent but extensive intraprostatic involvement. Cancer 1975;36:514-520.
32. Koch MO, Smith JA: Management of superficial bladder cancer Ta/T1/TIS. In Vogelzang NJ, Scardino PS, Shipley WU, et al. (eds): "Comprehensive Textbook of Genitourinary Oncology." Baltimore: Williams and Wilkens, 1996, 405-415.
33. Lamm DL, Toni FM: Bladder cancer, 1996. [Review] CA Cancer J Clin 1996;46:93-112.
34. Ozen H: Transitional cell carcinoma of the bladder. [Review] Curr Opin Oncol 1994;6:313-317.
35. Murphy WM, Crabtree WN, Jukkola AF: The diagnostic value of urine versus bladder washing in patients with bladder cancer. J Urol 1981;126:320-322.
36. Naib ZM: "Exfoliative Cytopatholoay." 3rd ed. Boston: Little, Brown, 1985, 427-430.
37. Pearson JC, Kromhout L, King EB: Evaluation of collection and preservation techniques for urinary cytolosy. Acta Cytol 1981;25:327-333.
38. Jakse G, Loidl W, Seeber G, Hofstadter F: Stage T1, grade 3 transitional cell carcinoma of the bladder: An unfavorable tumor? J Urol 1987;137:39-13.
39. Lahoti C, Schinella R, Rangwala AF, et al: Carcinosarcoma of urinary bladder: Report of 5 cases with immunohistologic study. Urology 1994;43:389-393.
40. Melicow MM, Hollowell JW: Intraurothelial cancer, carcinoma in situ, Bowen's disease of the urinary system: Discussion of 30 cases. J Urol 1952;68:763-772.
41. Melicow MM: Histological study of vesicle urothelium intervening between gross neoplasms in total cystectomy. J Urol 1952;68:261-279.
42. Koss LG: Precursor lesions of invasive bladder cancer. [Review] Eur Urol 1988;14(Suppl 1):4-6.
43. Melamed MR, Voutsa NG, Grabstald H: Natural history and clinical behavior of in situ carcinoma of the human urinary bladder. Cancer 1964;17:1533-1545.
44. Prout GR Jr, Griffin PP, Daly JJ, Heney NM: Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms. Cancer 1983;52:524-532.
45. Utz DC, Farrow GM, Rife CC, et al: Carcinoma in situ of the bladder. Cancer 1980;45(7 Suppl):1842-1848.
46. Zincke H, Utz DC, Farrow GM: Review of Mayo Clinic experience with carcinoma in situ. Urology 1985;26(4 Suppl):39-46.
47. Birch BR, Harland SJ: The pT1 G3 bladder tumor. [Review] Br J Urol 1989;64:109-116.
48. Reuter VE: Pathology of bladder cancer: Assessment of prognostic variables and response to therapy. [Review] Semin Oncol 1990;17:524-532.
49. Eble JN, Young RH: Benign and low-grade papillary lesions of the urinary bladder: A review of the papilloma-papillary carcinoma controversy, and report of five typical papillomas. [Review] Semin Diagn Pathol 1989;6:351-371.
50. Jordan AM, Weingarten J, Murphy WM: Transitional cell neoplasms of the urinary bladder. Can biological potential be predicted from histological grade? [published erratum appears in Cancer 1988;61:1385] Cancer 1987;60:2766-2774.
51. Utz DC, Farrow GM: Carcinoma in situ of the urinary tract. Urol Clin North Am 1984;11:735-740.
52. Murphy WM, Soloway MS: Urothelial dysplasia. [Review.] J Urol 1982;127:849-854.
53. Skinner DG: Current perspectives in the management of high-grade invasive bladder cancer. Cancer 1980;(7 Suppl)45:1866-1874.
54. Wood DP Jr, Montie JE: Bladder cancer, deciding on appropriate surgery. [Review] Oncology 1989;3:55-61; discussion 65-66, 68
55. Amin MB, Ro JY, el-Sharkawy T, et al: Micropapillary variant of transitional cell carcinoma of the urinary bladder: Histological pattern resembling ovarian papillary serous carcinoma. [comment in Am J Surg Pathol 1996;20:125-126] Am J Surg Pathol 1994; 18:1224-1232
56. Blomjous CE, Thunnissen FB, Vos W, et al: Small cell neuroendocrine carcinoma of the urinary bladder. An immunohistochemical and ultrastructural evaluation of 3 cases with a review of the literature. Virchows Archiv A Pathol Anat Histopathol 1988;413:505-512.
57. Grignon DJ, Ro JY, Ayala AG, et al: Small cell carcinoma of the urinary bladder. A clinicopathological analysis of 22 cases. Cancer 1992;69:527-536.
58. Lopez JI, Angulo JC, Flores N, Toledo JD: Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases. Br J Urol 1994;73:43-49.
59. Podesta AH, True LD: Small cell carcinoma of the bladder: Report of five cases with immunohistochemistry and review of the literature with evaluation of prognosis according to stage. Cancer 1989;64:710-714.
60. Yu DS, Chang SY, Wans J, et al: Small cell carcinoma of the urinary tract. [Review] Br J Urol 1990;66:590-595.
61. Torenbeek R, Blomjous CE, de Bruin PC, et al: Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol 1994;18:241-249.
62. Young RH, Wick MR, Mills SE: Sarcomatoid carcinoma of the urinary bladder. A clinicopathologic analysis of 12 cases and review of the literature. [Review] Am J Clin Pathol 1988;90:653-661.
63. Young RH: Carcinosarcoma of the urinary bladder. [Review] Cancer 1987;59:1333-1339.
64. Ro JY, Ayala AG, Wishnowk E, et al: Sarcomatoid bladder cancer: Clinicopathological and immunohistochemical study of 44 cases. Surg Pathol 1988;1:359-374.
65. Amin MB, Ro JY, Lee KM, et al: Lymphoepithelioma-like carcinoma of the urinary bladder. Am J Surg Pathol 1994;18:466-473.
66. Dinney CP, Roe JY, Babaian RJ, Johnson DE: Lymphoepithelioma of the bladder: a clinicopathological study of 3 cases. J Urol 1993;149:840-841.
67. Jones EC: "Lymphoepithelioma-like" carcinoma of the urinary bladder: a diagnostic challenge with biological and therapeutic implications. Adv Anat Pathol 1995;2:159-164.
68. Talbert ML, Young RH: Carcinoma of the urinary bladder with deceptively benign-appearing foci. A report of three cases. Am J Surg Pathol 1989;13:374-381.
69. Young RH, Zukerberg LR: Microcystic transitional cell carcinoma of the urinary bladder. A report of four cases. Am J Clin Pathol 1991;96:635-639.
70. Murphy WM, Deana DG: The nested variant of transitional cell carcinoma: A neoplasm resembling proliferation of Brunn's nests. Mod Pathol 1992;5:240-243.
71. Paulsen J, Metwalli N, Wu B: Transitional cell carcinoma of the bladder with features of inverted papilloma. [Abstract] Mod Pathol 1988;1:71A.
72. Henson DE, Fielding LP, Grignon DJ, et al: College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee. [Review] Arch Pathol Lab Med 1995;119: 1109-1112.
73. Angulo JC, Lopez JI, Grignon DJ, Sanchez-Chapado M: Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology 1995;45:47-53.
74. Hasui Y, Osada Y, Kitada S, Nishi S: Significance of invasion to the muscularis mucosae on the profession of superficial bladder cancer. Urology 1994;43:782-786.
75. Younes M, Sussman J, True LD: The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990;66:543-548.
76. Heney NM, Proppe K, Prout GR Jr, et al: Invasive bladder cancer Tumor configuration, lymphatic invasion and survival. J Urol 1983;130:895-897.
77. Bergman S, Javadpour N: The cell surface antigen A, B or O(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report. J Urol 1978;119:49-51.
78. Newman AJ Jr, Carlton CE Jr, Johnson S: Cell surface A, B or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma. J Urol 1980;124:27-29.
79. Richie JP, Blute RD Jr, Waisman J: Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens. J Urol 1980;123:22-24.
80. Wick MR, Zarbo RJ, Hitchcock CL: Special techniques for the pathologic analysis of lesions of the urinary bladder. In Young RH (ed): "Pathology of the Urinary Bladder." New York: Churchill Livingstone, 1989:285-349.
81. Blasco E, Rorrado J, Belloso L, et al: T-antigen. A prognostic indicator of high recurrence index in transitional carcinoma of the bladder. Cancer 1988;61:1091-1095.
82. Coon JS, Weinstein RS, Summers JL: Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 1982;77:692-699.
83. Fradet Y: Biolosical markers in prognosis in invasive bladder cancer. [Review] Semin Oncol 1990;17:533-543.
84. Lopez-Beltran A, Croghan GA, Croghan I, et al: Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study. Am J Clin Pathol 1994;102:109-114.
85. Pich A, Chiusa L, Comino A, Navone R: Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows Archiv 1994;424:143-148.
86. Vet JA, Debruyne FM, Schalken JA: Molecular prosnostic factors in bladder cancer. [Review] World J Urol 1994;12:84-88.
87. Ro JY, Staerkel GA, Ayala AG: Cytological and histologic features of superficial bladder cancer. [Review] Urol Clin North Am 1992;19:435-453
88. Kruger S, Muller H: Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas Br J Urol 1995;75:480-484.
89. Dean PJ, Murphy WM: Importance of urinary cytology and future role of flow cytometry. Urology 1985;(4 Suppl)26:11-15.
90. Cohen MB, Waldman FM, Carroll PR, et al: Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. [comment in Hum Pathol 1994;25:215-216] Hum Pathol 1993;24:772-778.
91. Cordon-Cardo C, Dalbagni G, Sarkis AS, Reuter VE: Genetic alterations associated with bladder cancer. [Review] Important Adv Oncol 1994:71-83.
92. Ramaekers FC, Hopman AH: Detection of genetic aberrations in bladder cancer usina in situ hybridization. [Review] Ann N Y Acad Sci 1993;677:199-213.
93. Simoneau AR, Jones PA: Bladder cancer: The molecular progression to invasive disease. [Review] World J Urol 1994;12:89-95.
94. Soini Y, Turpeenniemi-Hujanen T, Kamel D, et al: p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer 1993;68:1029-1035
95. Uchida T, Wada C, Ishida H, et al: p53 mutations and prognosis in bladder tumors J Urol 1995;153:1097-1104.
96. Cordon-Cardo C, Wartinger D, Petrylak D, et al: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. [comment in J Natl Cancer Inst 1992;84:1226-1227] J Natl Cancer Inst 1988;84:1251-1256.
97. Logotheus CJ, Xu HJ, Ro JY, et al: Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. [comment m J Natl Cancer Inst 1992;84:1226-1227] J Natl Cancer Inst 1988;84:1256-1261.